Reaction

Bronchial Obstruction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,389 reports · 41 co-occurring drugs

As of the last recalculation, Bronchial Obstruction appears in 1,389 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is MEPOLIZUMAB (PRR 67.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Mepolizumab	192	67.0	67.3
Ciclesonide	54	61.8	62.0
Theophylline	45	60.6	60.8
Theophylline Anhydrous	47	58.8	59.0
Fluticasone Furoate And Vilanterol Trifenatate	107	48.2	48.4
Tiotropium Bromide Inhalation Spray	34	46.6	46.7
Mometasone	50	42.3	42.4
Mometasone Furoate	84	32.1	32.1
Benralizumab	37	28.4	28.5
Cortisone Acetate	22	27.1	27.2
Montelukast Sodium	179	25.1	25.2
Dalteparin Sodium	17	24.4	24.4
Omalizumab	112	21.3	21.4
Tiotropium Bromide	158	19.4	19.4
Palivizumab	19	18.8	18.8
Erythromycin	22	17.8	17.9
Fluticasone Propionate And Salmeterol Xinafoate	60	15.6	15.6
Albuterol Sulfate	243	14.7	14.7
Rocuronium Bromide	11	14.1	14.1
Rizatriptan Benzoate	9	13.3	13.3
Montelukast	66	12.3	12.3
Budesonide And Formoterol Fumarate Dihydrate	74	12.0	12.0
Pseudoephedrine Hydrochloride	8	11.7	11.7
Ceftriaxone Sodium	29	11.6	11.6
Pseudoephedrine Hcl	8	10.9	10.9
Lumacaftor And Ivacaftor	6	10.5	10.5
Salmeterol Xinafoate	6	10.5	10.5
Brinzolamide	6	10.4	10.4
Fluticasone Furoate	8	9.9	10.0
Ceftriaxone	21	9.7	9.7
Amikacin	10	8.8	8.8
Pegaspargase	6	7.4	7.4
Umeclidinium	4	6.7	6.7
Pemetrexed Disodium	16	6.4	6.4
Dornase Alfa	8	6.1	6.1
Brimonidine Tartrate	7	5.9	5.9
Tobramycin	9	5.6	5.6
Umeclidinium Bromide And Vilanterol Trifenatate	6	5.4	5.4
Cetuximab	11	5.3	5.3
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	4.3	4.3
Crizotinib	3	3.5	3.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.